NCT02707627

Brief Summary

A new era of outcomes for pediatric burn patients has begun as burn care continues to improve. Unfortunately, complete restoration of burn-injured skin may be limited by the development of hypertrophic scarring. Treatment with laser therapy is one of the newest forms of scar therapy available. Although laser therapy has only been adopted by burn clinicians within the last several years, early evidence suggests that it may offer significant benefits. Thus the aim of this study is to investigate the effectiveness of using laser therapy to treat hypertrophic burn scars in pediatric patients by using a comprehensive set of subjective and objective scar assessment tools.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 14, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

August 17, 2021

Status Verified

August 1, 2021

Enrollment Period

3.6 years

First QC Date

March 3, 2016

Last Update Submit

August 16, 2021

Conditions

Keywords

PediatricLaserBurnScarPhotothermolysis

Outcome Measures

Primary Outcomes (1)

  • Vancouver Scar Scale Score

    The Vancouver Scar Scale is composed of four subscales which include pigmentation (range: 0 - 3), vascularity (range: 0 - 3), pliability (range: 0 - 5), and height (range: 0 - 3). Total Vancouver Scar Scale score refers to the score obtained by summing the values from each subscale (range: 0 - 14) with higher scores indicating a worse scar.

    Baseline (month 0) to month 12

Secondary Outcomes (5)

  • Patient and Observer Scar Assessment Scale Score

    Baseline (month 0) to month 12

  • Scar thickness

    Baseline(month 0) to month 12

  • Scar stiffness measured by the DermaLab Combo® skin analysis device

    Baseline(month 0) to month 12

  • Scar stiffness measured by ultrasound elastographgy

    Baseline(month 0) to month 12

  • Scar colour

    Baseline(month 0) to month 12

Study Arms (1)

Laser Therapy

Participants will receive laser therapy for the treatment of their hypertrophic burn scars. Laser treatment decisions will be tailored to meet the needs of the patient.

Device: Laser Therapy

Interventions

Laser therapy is a technology that can be used to treat hypertrophic burn scars.

Laser Therapy

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Eligible participants will be pediatric patients with hypertrophic scars requiring treatment.

You may qualify if:

  • Age 1-18 years at presentation
  • Patients with a hypertrophic burn scar that has been clinically diagnosed by a burn care specialist
  • Hypertrophic burn scar resulting from any etiology
  • Hypertrophic burn scar is ≥ 2 months post healing
  • Ability to complete English- language questionnaires

You may not qualify if:

  • Patients with concomitant skin disease (i.e. chronic skin conditions, herpes infection)
  • Patients with a history of keloid scarring
  • Patients who cannot tolerate the intravenous (IV) sedation used to perform laser therapy procedures
  • Patients who have had previous laser therapy procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Sick Children

Toronto, Ontario, M5G1X8, Canada

Location

MeSH Terms

Conditions

Cicatrix, HypertrophicBurnsCicatrix

Interventions

Laser Therapy

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsWounds and Injuries

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director, Burn Program

Study Record Dates

First Submitted

March 3, 2016

First Posted

March 14, 2016

Study Start

October 1, 2016

Primary Completion

May 1, 2020

Study Completion

January 1, 2021

Last Updated

August 17, 2021

Record last verified: 2021-08

Locations